Skip to content
A Blog by Biocon

A Blog by Biocon

  • Home
  • About Us
  • Biocon Biologics
    • Biocon Biologics @ IDF Congress 2019
      • Speaker Profiles
    • Itolizumab (ALZUMAb®) : Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19
  • Healthcare
  • Innovation
  • Policy
  • Biosimilars
  • Disease Epidemiology
  • Bioconites Corner
    • Work From Home
    • Campaigns
      • Mother’s Day
      • Lupus Day
  • Comments Policy
  • Contact

Category: Biosimilars

November 27, 2017December 5, 2017 Biocon Biosimilars, Disease Management, Healthcare, Innovation

‘KRABEVA®’s Unique ‘Qual-Check’ Mechanism Ensures Patients Get a Quality-Ascertained Product’: Suresh Subramanian

Mr. Suresh Subramanian, Senior Vice President & Head Branded Formulations, Biocon shares his views on how KRABEVA® can make a significant impact in the biosimilars space.

October 22, 2016October 24, 2016 Biocon Biosimilars

‘Stand-out’ Quarter for Biocon’s Biologics Business

Biocon reported strong Q2FY17 results. Small Molecules, Biologics and Research Services businesses showed strong growth while it was a stand-out quarter for the Biologics business.

October 14, 2016October 14, 2016 Biocon Biosimilars

Realizing the Promise of Biosimilars in 2020

Part 2 – The potential financial benefits and better health outcomes from biosimilars use could spur their uptake in health systems globally.

August 1, 2016October 14, 2016 Biocon Biosimilars

Access and Affordability: Impact of Biosimilars

Part 1 – Biosimilars can provide cost-effective, high quality alternatives to expensive reference biologics, thus improving access and expanding the patient base.

Posts navigation

Newer posts

Itolizumab: Highly Promising Therapy for Cytokine Release Syndrome (CRS) in COVID-19

DCGI Approval for emergency use of Itolizumab in treatment of Covid-19

Biocon Biologics on Twitter

My Tweets

Biocon Biologics on Facebook

Biocon Biologics on Facebook

Biocon on Twitter

My Tweets

Search

Biocon Limited

20th KM, Hosur Road,
Electronic City,
Bangalore, India - 560 100
Email: contact.us@biocon.com
+91 80 2808 2808 / 91 80 4014 4014

Social

  • View bioconlimited’s profile on Facebook
  • View Bioconlimited’s profile on Twitter
  • View bioconlimited’s profile on YouTube

Archives

DISCLAIMER

Please read our Disclaimer and Comments Policy before engaging on our blog!

Create a website or blog at WordPress.com
Cancel

 
Loading Comments...
Comment
    ×